Retinal stem cell transplantation: Balancing safety and potential
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Stem cell transplantation holds great promise as a potential treatment for currently incurable retinal degenerative diseases that cause poor vision and blindness. Recently, safety data have emerged from several Phase I/II clinical trials of retinal stem cell transplantation. These clinical trials, usually run in partnership with academic institutions, are based on sound preclinical studies and are focused on patient safety. However, reports of serious adverse events arising from cell therapy in other poorly regulated centers have now emerged in the lay and scientific press. While progress in stem cell research for blindness has been greeted with great enthusiasm by patients, scientists, doctors and industry alike, these adverse events have raised concerns about the safety of retinal stem cell transplantation and whether patients are truly protected from undue harm. The aim of this review is to summarize and appraise the safety of human retinal stem cell transplantation in the context of its potential to be developed into an effective treatment for retinal degenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116 · cited 1×
“The advent of CRISPR gene editing technology (Jinek et al., 2012; Mali et al., 2013) may provide avenues to correct genetic mutations in self-derived stem cells (Burnight et al.”
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · cited 1×
“Modern stem cell technologies have yielded clinical grade cellular therapies that are under investigation for retinal degenerations from both human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) (Drukker et al., 2006; Odorico et al., 2001; Polak and Bishop, 2006; Takahashi et al., 2007; Yu et…”
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210 · cited 1×
“The advent of CRISPR gene editing technology (Jinek et al., 2012; Mali et al., 2013) may provide avenues to correct genetic mutations in self-derived stem cells (Burnight et al.”
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725 · cited 3×
“Background data The investigators selected CD34 + cells from bone marrow as the target cell therapy since these cells are known to be mobilized into the systemic circulation from bone marrow in response to tissue injury as part of the normal repair mechanism of the body (Asahara et al., 1997; Park, 2016).”
Kern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K. (2006) · STEM CELLS · doi:10.1634/stemcells.2005-0342 · Cited by 3,370 · cited 1×
“(Hankin and Lund, 1987; Kirschen McLoon et al., 1981).”
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292 · cited 1×
“Its future use in removing disease-causing mutations in therapeutic cells may pose additional risks related to off-target mutagenesis (Fu et al., 2013) that will need to be comprehensively characterized, understood and mitigated as far as possible prior to clinical application in autologous stem cell therapy.”
Mesenchymal stem cells as trophic mediators
Caplan, A. I., & Dennis, J. E. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20886 · Cited by 2,992
Hartong, D. T., Berson, E. L., & Dryja, T. P. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69740-7 · Cited by 2,924
The Retinal Pigment Epithelium in Visual Function
Strauss, O. (2005) · Physiological Reviews · doi:10.1152/physrev.00021.2004 · Cited by 2,828
Adipose-derived stem cells for regenerative medicine
Gimble, J. M., Katz, A. J., & Bunnell, B. A. (2007) · Circulation Research · doi:10.1161/01.res.0000265074.83288.09 · Cited by 2,332 · cited 1×
“It is possible that the preparations of adipose-derived “stem cells” used for intravitreal injection, may include autologous fibroblasts or cells that differentiate into autologous fibroblasts (Gimble et al., 2007).”
Self-formation of optic cups and storable stratified neural retina from human ESCs
Nakano, T., Ando, S., Takata, N., Kawada, M., Muguruma, K., Sekiguchi, K., Saito, K., Yonemura, S., Eiraku, M., & Sasai, Y. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.05.009 · Cited by 1,447 · cited 1×
“Subsequently, it was shown that under appropriate three-dimensional (3D) culture conditions, ESC and iPSC are capable of differentiating into selforganizing 3D retinal tissue with the different major retinal cell types arranged in their proper layers (Meyer et al., 2011; Nakano et al., 2012; Phillips et al., 2012; Zho…”
Schwank, G., Koo, B.-K., Sasselli, V., Dekkers, J. F., Heo, I., Demircan, T., Sasaki, N., Boymans, S., Cuppen, E., van der Ent, C. K., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.11.002 · Cited by 1,424 · cited 1×
“CRISPR gene editing has been used to correct diseasecausing mutations in stem cell organoids of cystic fibrosis (Schwank et al., 2013), colorectal cancer (Roper et al.”
Isolation of multipotent mesenchymal stem cells from umbilical cord blood
Lee, O. K., Kuo, T. K., Chen, W.-M., Lee, K.-D., Hsieh, S.-L., & Chen, T.-H. (2004) · Blood · doi:10.1182/blood-2003-05-1670 · Cited by 1,360
Schwartz, S. D., Regillo, C. D., Lam, B. L., Eliott, D., Rosenfeld, P. J., Gregori, N. Z., Hubschman, J.-P., Davis, J. L., Heilwell, G., Spirn, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61376-3 · Cited by 1,327
Self-citationHuman bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age
Pang, W. W., Price, E. A., Sahoo, D., Beerman, I., Maloney, W. J., Rossi, D. J., Schrier, S. L., & Weissman, I. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116110108 · Cited by 991 · cited 1×
“CD34 + cells in human) and even fewer mesenchymal stem cells (Pang et al., 2011; Posel et al., 2012).”
Non-syndromic retinitis pigmentosa
Verbakel, S. K., van Huet, R. A. C., Boon, C. J. F., den Hollander, A. I., Collin, R. W. J., Klaver, C. C. W., Hoyng, C. B., Roepman, R., & Klevering, B. J. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.03.005 · Cited by 973
Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs
Zhong, X., Gutierrez, C., Xue, T., Hampton, C., Vergara, M. N., Cao, L.-H., Peters, A., Park, T. S., Zambidis, E. T., Meyer, J. S., et al. (2014) · Nature Communications · doi:10.1038/ncomms5047 · Cited by 970
Self-citationMultilineage differentiation from human embryonic stem cell lines
Odorico, J. S., Kaufman, D. S., & Thomson, J. A. (2001) · Stem Cells · doi:10.1634/stemcells.19-3-193 · Cited by 969 · cited 1×
“Modern stem cell technologies have yielded clinical grade cellular therapies that are under investigation for retinal degenerations from both human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) (Drukker et al., 2006; Odorico et al., 2001; Polak and Bishop, 2006; Takahashi et al., 2007; Yu et…”
Hamel, C. (2006) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-1-40 · Cited by 962
Idelson, M., Alper, R., Obolensky, A., Ben-Shushan, E., Hemo, I., Yachimovich-Cohen, N., Khaner, H., Smith, Y., Wiser, O., Gropp, M., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.07.002 · Cited by 486 · cited 10×
“In contrast to ESCs and iPSCs, adult RPE stem cells (RPESCs) provide a completely different lineage-committed source for deriving RPE cells for transplantation.”
InfluentialSharma, A., Burridge, P. W., McKeithan, W. L., Serrano, R., Shukla, P., Sayed, N., Churko, J. M., Kitani, T., Wu, H., Holmström, A., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf2584 · Cited by 404
Drukker, M., Katchman, H., Katz, G., Even-Tov Friedman, S., Shezen, E., Hornstein, E., Mandelboim, O., Reisner, Y., & Benvenisty, N. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0188 · Cited by 402 · cited 1×
“Modern stem cell technologies have yielded clinical grade cellular therapies that are under investigation for retinal degenerations from both human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) (Drukker et al., 2006; Odorico et al., 2001; Polak and Bishop, 2006; Takahashi et al., 2007; Yu et…”
Dysfunctional autophagy in RPE, a contributing factor in age-related macular degeneration
Golestaneh, N., Chu, Y., Xiao, Y.-Y., Stoleru, G. L., & Theos, A. C. (2017) · Cell Death & Disease · doi:10.1038/cddis.2016.453 · Cited by 357 · cited 1×
“For instance, recent evidence suggests that cadaveric RPE cells may retain cellular endophenotypes of aging and disease which may limit their potential as an effective therapeutic substrate (Golestaneh et al., 2017).”
Bharti, K., Nguyen, M. T., Skuntz, S., Bertuzzi, S., & Arnheiter, H. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00318.x · Cited by 237
Self-citationSugita, S., Iwasaki, Y., Makabe, K., Kamao, H., Mandai, M., Shiina, T., Ogasawara, K., Hirami, Y., Kurimoto, Y., & Takahashi, M. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.08.010 · Cited by 156
Self-citationMay-Simera, H. L., Wan, Q., Jha, B. S., Hartford, J., Khristov, V., Dejene, R., Chang, J., Patnaik, S., Lu, Q., Banerjee, P., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.038 · Cited by 150 · cited 15×
“In a further experiment, undifferentiated hESCs were spiked into the RPE cell culture (from 1% to 50% dose of the total cells) at the start of the expansion phase.”
InfluentialSelf-citationBirch, D. G., Bennett, L. D., Duncan, J. L., Weleber, R. G., & Pennesi, M. E. (2016) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2016.07.013 · Cited by 112 · cited 1×
“Over 60–96 months, there was no evidence of therapeutic benefit of CNTF administration for visual acuity, visual field sensitivity, or retinal structure in treated subjects (Birch et al., 2016).”
Lipids, oxidized lipids, oxidation-specific epitopes, and Age-related macular degeneration.
Handa, J. T., Cano, M., Wang, L., Datta, S., & Liu, T. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.07.013 · Cited by 112
The culture and maintenance of functional retinal pigment epithelial monolayers from adult human eye
Blenkinsop, T. A., Salero, E., Stern, J. H., & Temple, S. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-125-7_4 · Cited by 96 · cited 4×
“While the restricted lineage potential of adult RPESCs suggests possibly enhanced safety over that of ESC- and iPSC-derived RPE cells, adult RPESC derived RPE cells may present other challenges.”
InfluentialDeveloping cellular therapies for retinal degenerative diseases
Bharti, K., Rao, M., Hull, S. C., Stroncek, D., Brooks, B. P., Feigal, E., van Meurs, J. C., Huang, C. A., & Miller, S. S. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-13481 · Cited by 77
Self-citationSUBRETINAL CELL-BASED THERAPY: An Analysis of Surgical Variables to Increase Cell Survival
Wilson, D. J., Neuringer, M., Stoddard, J., Renner, L. M., Bailey, S., Lauer, A., & McGill, T. J. (2017) · Retina · doi:10.1097/iae.0000000000001462 · Cited by 25
Epiretinal membrane in a subject after transvitreal delivery of palucorcel (CNTO 2476)
Spencer, R., Fisher, S., Lewis, G. P., & Malone, T. (2017) · Clinical Ophthalmology · doi:10.2147/opth.s140218 · Cited by 16 · cited 1×
“Histological data regarding an epiretinal membrane removed from a patent that received CNTO-2476 ERM indicated the presence of both subject (self) cells and palucorcel (Spencer et al., 2017).”
Cited by
Subretinal injection techniques for retinal disease: A review
Irigoyen, C., Amenabar Alonso, A., Sanchez-Molina, J., Rodríguez-Hidalgo, M., Lara-López, A., & Ruiz-Ederra, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164717 · Cited by 106
“At the moment, there are no FDA-approved gene or stem cell-based therapies targeting other genetic subtypes of retinal diseases [37].”
BackgroundFirst-in-Human robot-assisted subretinal drug delivery under local anesthesia
Cehajic-Kapetanovic, J., Xue, K., Edwards, T. L., Meenink, T. C., Beelen, M. J., Naus, G. J., de Smet, M. D., & MacLaren, R. E. (2022) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2021.11.011 · Cited by 78
Self-citationSpatial Patterns and Age-Related Changes of the Collagen Crimp in the Human Cornea and Sclera
Gogola, A., Jan, N.-J., Brazile, B., Lam, P., Lathrop, K. L., Chan, K. C., & Sigal, I. A. (2018) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.17-23474 · Cited by 59
Metadata
- Authors
- Singh, M. S., Park, S. S., Albini, T. A., Canto-Soler, M. V., Klassen, H., MacLaren, R. E., Takahashi, M., Nagiel, A., Schwartz, S. D., & Bharti, K.
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 75
- Pages
- 100779
- ISSN
- 1350-9462 (ISSN-L)
- OpenAlex
- W2971597914
- Cited by
- 225
- References
- 34
- FWCI
- 7.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.